Quantum量子訊息有限公司
← 最新全球產業報告

Non-Invasive Biosensor Market

研究執行與發布:Coherent Market Insights · 發布日期 2026-05-28 · 254 頁
由量子訊息有限公司(Quantum Information)在台灣代理銷售與提供授權諮詢。

2026 年市場規模
USD 7.5 Bn
2033 年預估規模
USD 16.7 Bn
年複合成長率 CAGR
12.5%

以上數字由 Coherent Market Insights 於本報告中提出,量子訊息原樣引用。

出版商 Coherent Market Insights產業別 Medical Devices出版日期 2026-05-28頁數 254報告編號 CMI1704

授權報價

Single User Price$4,500 USD
Enterprise License$10,000 USD
洽詢購買 申請 Sample
完整報告名稱與涵蓋範圍
Non-Invasive Biosensor Market, By Technology (Optical, Transdermal, Thermal, Others), By Product Type (Glucose monitors, Blood Analytes Monitors, Breathalyzers, Others), By End User (Homecare Settings, Hospitals, Diagnostic Lab, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

報告摘要

Non-invasive biosensors are novel diagnosis devices, which do not require any invasive procedure for detection of any substance or disease. This technology uses sweat, tears, or saliva for diagnostic purpose. Glucose monitoring and blood analytes monitor have become available in the market, which uses non-invasive biosensors. Moreover, there are many non-invasive biosensors under development and under clinical trial for new applications such as cancer and blood alcohol concentration detection. Market Dynamics Increasing approval and launches of novel non-invasive biosensors is expected to boost growth of global non-invasive biosensors market in the near future. For instance, in 2016, Nemaura Medical, Inc. received CE approval in the European Union for its latest sugarBEAT, a minimally invasive wireless continuous glucose monitor. Moreover, in 2013, Integrity Applications Inc. received CE marking for its new GlucoTrack DF-F device, a non-invasive blood glucose monitoring device. Increasing research and development activities for developing novel non-invasive biosensors is also expected to drive growth of market in the near future. For instance, in 2017, Mclean Hospital announced that LabPatch-alcohol, its non-invasive skin patch that detects blood alcohol concentration, is in clinical trial. LabPatch-alcohol is in early Phase 1 stage of clinical trial. Furthermore, increasing prevalence of diabetes is also expected to increase demand for non-invasive biosensors for diagnosis. According to the World Health Organization (WHO), 2014, around 8.5% of adults aged 18 and above accounting for 422 million adults were suffering from diabetes worldwide. Key features of the study • This report provides in-depth analysis of non-invasive biosensors market and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2026 – 2033), considering 2025 as the base year • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players • It profiles leading players in the global non-invasive biosensors market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans • Key companies covered as a part of this study include Nemaura Medical, Inc., MediWise Ltd., Integrity Applications Inc., OrSense, Medtronic Plc, GE Healthcare, Philips Healthcare, Akers Biosciences, Inc. and Abbott Laboratories • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics • The global non-invasive biosensors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the non-invasive biosensors market Market Segmentation • By Technology (Revenue, USD Bn, 2021-2033) o Optical o Transdermal o Thermal o Others • By Product Type (Revenue, USD Bn, 2021-2033) o Glucose monitors o Blood Analytes Monitors o Breathalyzers o Others • By End User (Revenue, USD Bn, 2021-2033) o Homecare Settings o Hospitals o Diagnostic Lab o Others • By Region (Revenue, USD Bn, 2021-2033) o North America  U.S.  Canada o Latin America  Brazil  Mexico  Argentina  Rest of Latin America o Europe  Germany  U.K.  France  Italy  Spain  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC  Israel  Rest of Middle East o Africa  South Africa  Central Africa  North Africa • Key Players o Nemaura Medical, Inc. o MediWise Ltd. o Integrity Applications Inc., o OrSense o Medtronic Plc o GE Healthcare o Philips Healthcare o Akers Biosciences, Inc. o Abbott Laboratories.
目錄 Table of Contents
Table of Contents 1. Research Objective and Assumption o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snippet, By Technology  Market Snippet, By Product Type  Market Snippet, By End User  Market Snippet, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Market Opportunities o Recent Product Approval/Launch o Pipeline Analysis o Regulatory Scenario o Reimbursement Scenario o PEST Analysis o PORTER Analysis o Epidemiology 4. Global Non-Invasive Biosensors Market, By Technology, 2021–2033 (US$ Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022–2033  Segment Trends o Optical  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn) o Transdermal  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn) o Thermal  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn) 5. Global Non-Invasive Biosensors Market, By Product Type, 2021–2033 (US$ Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022–2033  Segment Trends o Glucose monitors  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn) o Blood Analytes Monitors  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn) o Breathalyzers  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn) 6. Global Non-Invasive Biosensors Market, By End User, 2021–2033 (US$ Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022–2033  Segment Trends o Hospitals  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn) o Diagnostic Lab  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn) o Homecare Settings  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn) 7. Global Non-Invasive Biosensors Market, By Region, 2021–2033 (US$ Bn) o Introduction  Market Share Analysis, By Region, 2026 and 2033 (%)  Y-o-Y Growth Analysis, For Regions, 2021–2033 o North America  Introduction  Market Size and Forecast, By Technology, 2021–2033 (US$ Bn)  Market Size and Forecast, By Product Type, 2021–2033 (US$ Bn)  Market Size and Forecast, By End User, 2021–2033 (US$ Bn)  Market Size and Forecast, By Country, 2021–2033 (US$ Bn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, By Technology, 2021–2033 (US$ Bn)  Market Size and Forecast, By Product Type, 2021–2033 (US$ Bn)  Market Size and Forecast, By End User, 2021–2033 (US$ Bn)  Market Size and Forecast, By Country, 2021–2033 (US$ Bn) o Brazil o Mexico o Argentina o Rest of Latin America o Europe  Introduction  Market Size and Forecast, By Technology, 2021–2033 (US$ Bn)  Market Size and Forecast, By Product Type, 2021–2033 (US$ Bn)  Market Size and Forecast, By End User, 2021–2033 (US$ Bn)  Market Size and Forecast, By Country, 2021–2033 (US$ Bn) o U.K. o Germany o Italy o France o Spain o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, By Technology, 2021–2033 (US$ Bn)  Market Size and Forecast, By Product Type, 2021–2033 (US$ Bn)  Market Size and Forecast, By End User, 2021–2033 (US$ Bn)  Market Size and Forecast, By Country, 2021–2033 (US$ Bn) o China o India o Japan o ASEAN o Australia o South Korea o Rest of APAC Japan o Australia o Middle East  Introduction  Market Size and Forecast, By Technology, 2021–2033 (US$ Bn)  Market Size and Forecast, By Product Type, 2021–2033 (US$ Bn)  Market Size and Forecast, By End User, 2021–2033 (US$ Bn)  Market Size and Forecast, By Country, 2021–2033 (US$ Bn) o GCC o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, By Technology, 2021–2033 (US$ Bn)  Market Size and Forecast, By Product Type, 2021–2033 (US$ Bn)  Market Size and Forecast, By End User, 2021–2033 (US$ Bn)  Market Size and Forecast, By Country, 2021–2033 (US$ Bn) o Central Africa o South Africa o North Africa 8. Competitive Landscape o Heat Map Analysis o Company Profiles  Nemaura Medical, Inc. o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  MediWise Ltd. o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Integrity Applications Inc. o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  OrSense o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Medtronic Plc o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  GE Healthcare o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Philips Healthcare o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Akers Biosciences, Inc. o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Abbott Laboratories o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies 9. Section o References o Research Methodology o About us and Sales Contact Browse 42 market data tables and 38 figures on “Non-Invasive Biosensors Market - Global forecast to 2026”.

提及公司

Nemaura Medical, Inc.MediWise Ltd.Integrity Applications Inc.,OrSenseMedtronic PlcGE HealthcarePhilips HealthcareAkers Biosciences, Inc.Abbott Laboratories.

同分類最新報告(醫療器材)

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們